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Immunologic Biomarkers Associated with
an Acute Exposure to Exothermic
Byproducts of a Ureaformaldehyde Spill
by Roberta E. Madison,* Alan Broughton,t and
Jack D. Thrashert
Acommunity wasexposedforseveraldaystoformaldehyde(HCHO),hexamthylenetetramine, trimethylamine, and
parafo alehydeemittedfromanoverheat tankercarcont g foimldehyderesn.Residentsexperiencedacute
HCHOsymptomsatthetimeoftheaccident. Many developedchronic, multiple organhealthcomplaints. Threeyears
followingtheaccident, exposedsubjectswer comparedtoresidentsofanearbyunexposedcommunity forthefolowing
immunological parameters: whitebloodcellcount,totallymphocytecount,percentandtotallymphocytesubsets(CDS,
CD4,CD8,CD19,CD25, andCD26cells),preveanc ofautoantibodies,andantibodiestoHCHO-humanserumalbumin
(HCHO-HSA) conjugate. Thedatawereadjusted forgender, age, historyof king, mobilehomeresidency, and use
ofwood stoves. Therewasastatistically sificantdifferenceforthefollowing:elevatedpercentandabsolutenumbers
ofCD26cells(p < OO01);autoantibodies(p <0.004),andgreatertitersofisotypesIgG (p <00005)andIgM(p <0.005)
toHCHO-HSA. Itisconcludedthattheexposedsubjectshadanactivatedimmunesysteminadditiontotheelevatedau-
toantibodies. Also,isotypestoHCHO-HSAresultedfromtheexposureandnoothersources, such assmoking, mobilehome
residency, anduseofwoodstoves.
Introduction
Chronic, low-level inhalation exposureofhumanstoformalde-
hyde (HCHO) is associated with antibodies to HCHO-human
serumalbumin(HCHO-HSA)conjugate(1-5) aswell aselevated
CD26 cells and autoantibodies (5). Other pertubations in im-
munologic parameters includeincreasedproductionofhistamine
(6), thromboxane B-2, and PGE-2 (7). Commensurate with
thesefindings arehealthcomplaints indicativeofimmunologic
sensitivity (1,6,7) as well as multiple organ symptoms (4,5).
Thus, HCHOis animmunogen underchronic, low-level inhala-
tion exposure.
In March 1986, asmallcommunity inAlaska wasexposed to
HCHOandotherreactantsemittingfromanoverheatedtankercar
filledwithureaformaldehyde resin. TheAlaskaDepartmentof
HealthandSocialServicesreportedinitial symptoms werecon-
sistent with exposure to HCHO and reactants (trimethylamine
[TMA],paraformaldehyde[PFA],andhexamethylenetetrmmine
[HMTA]). Inaddition,50%ofthoseexposedhadmultiple, recur-
rent, unresolvedhealthcomplaints2monthsfollowingthespill
(8). In this study we presentevidence that the lingering health
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problems are associated with an activated immune system
(elevatedCD26cells), autoantibodies, andisotypestoHCHO-
HSAconjugate.
Materials and Methods
TbnkerVentingandHCHO Concentrations
Arailroadtankercarcontaining 190,000lbofureaformaldehyde
resinunderwentuncontrolledventing inCrown Point, Alaska,
March 1986, averageambienttemperatureof0°F. Theureafor-
maldehydeconcentratehadthefollowingcomposition: HCHO
(59.6-60.4%), urea (24.5-25.5%), TMA (1%), and methanol
(lessthan1%maximum).Thetankercarwasinitiallysteamheated
(about 150°F) inanticipationoftransport. Approximately 12hr
laterthetankercontentswereagainsteamheatedforanadditional
48to49hr.Thetemperatureofthetankerwasmeasuredat2010F,
whileinteriorsteamcoilsattainedtemperaturesexceeding300°F.
Releaseofammoniafromtheureabegananexothermicreaction
formingHMTA,carbondioxide,andwater.Approxiimately3days
later,theinternalpressureincreased,andvigorousventingbegan
onMarch1.Duringthenext48hr,between85,000to99,000lbof
chemical reactants were released. The most likely vented
byproductswerecarbondioxide, water,HCHO,HMTA,TMA,
PFA,andammonia.Thecommunitywasevacuatedonday2and
givenpermissiontoreturnonday3followingtheinitialventing.
Theresidents notedastrong "fishodor" attributedtoTMAfor
severalweeksfollowing theaccident.MADISONETAL.
BeginningonMarch4, officials fromtheEnvironmental Pro-
tection Agency (EPA) region 10andthe Alaska Departmentof
Environment Conservationbeganenvironmental monitoring in
coordinationwiththeAlaskaRailroadCorporation. Ambientair
and snow samples werecollected atapproximately 31 different
sites in Crown Point. Escaping gas was also sampled. For-
maldehyde samples were collected by midget impingers in
distilled waterat 1 L/minfor I to2hrandanalyzedbyNational
Institute of Occupational Safety and Health (NIOSH) P and
CAM method 125. Air amine levels were obtained using SKC
amine collection tubes #2614, Bendix 44 personal monitor
samplerpumpandanalyzedbyNIOSHPandCAMmethod221.
Snowsamples werecollectedbyscrapingoffthe 'Ato 1/2 inchof
snow surfaceandanalyzed by NIOSH PandCAMmethod 125
(9). Ambient concentrations of HCHO during the first 48 hr
wereestimatedwithaPasquillatmospheric stability classifica-
tionofC(day)andF(night)withasourceof56,000mg/secand
a sourceheightof33 feet(10). According totheseassessments,
thecitizensofCrownPointwereconsideredexposedtoHCHO
and reactants emitted from thetanker car.
Exposed andUnexposed Subjects
Theexposedsubjectsconsistedof42individuals(21 males, 21
females) age34 ± 16.6years (range4-68), whowerepresentat
thetimeofthe spill at Crown Point. Subjects werereferred for
diagnostic testing by their physician. A survey research firm
solicited 29 unexposed volunteers (13 males, 16 females) age
54 + 19 (range 14-80) fromthecommunity ofCooperLanding
asacomparison group. CooperLandingislocatedwestandup-
windS to 10milesofCrownPoint. Theplumefromtheventing
moved eastward, never reaching Cooper Landing.
Blood Collection
Blood samples were drawn approximately 3 years following
theaccident. Thesamplesfrombothgroups werecollectedand
labeledundersupervisionofanattendingphysicianusingsilicon-
treated, heparinized glassevac-tubes. Thebloodsamples were
transported tothelaboratory by anovernightcarrierandwereus-
edwithin24hrfollowingcollection. Uponarrival, thespecimens
wereassignedacomputer-generated accessionnumber. Quali-
tyassurance wasperformedbypositiveandnegativecontrols run
simultaneously with the unknown samples. Cell viability was
90% by trypan blue exclusion.
HCHO-HSA Conjugation and ELISA Antibody
Assay
IgE, IgM, and IgG anti-HCHO-HSA antibodies were deter-
minedby anenzyme-linked immunoassay (ELISA) procedure
asdescribedelsewhere(5), excepttheconjugate wasnotfrozen.
Lymphocyte SurfaceMarkers
Allprocedures wereperformedonheparinized venous blood
within24hrfollowingcollection. Thetotalperipheralwhitecell
(WBC) and lymphocyte counts were performed using a
CoulterT540counter(Coulter, Florida). Lymphocytemarker
procedures aredescribedelsewhere (2,5). Inbrief, peripheral
mononuclearcellswereisolatedby Ficoll Hypaquedensitygra-
dient(12). Thepercentages andabsolutenumbersoflymphocte
subsets per cubic centimeter of blood were enumerated by
fluorescentmicroscopyusingmonoclonal antibodies to surface
markers as follows: CD5 (LEUl, T-cells), CD5 (LEU3A, T-
helpercells), CD8 (LEU2A, T-suppressorcells), CD19(LEUIO,
B-cells), (Beckton-Dickinson, Los Angeles, California) and
CD25 (IL2+ receptor cells) and CD26 (Tal+ cells) (Coulter,
Florida). Allsurfacemarkers, exceptCD26, wereidentifiedby
indirectimmunofluorescence (13). CD26cells weredetermin-
edby adirectimmunofluorescent method (14).
Autoantibody Screen
Antismoothmuscle(ASS), antiparietal cell (APA), antibrush
border(ABB), antimitochondrial (AMA), andantinuclear au-
toantibodiesinthesubjects' seraweredetectedbyanindirectim-
munofluorescent method andexpressed as positiveat atiter of
1:20 (15).
Statistical Methods
Two-tailedt-testswereperformedtodeterminewhetherthere
was a difference between the two groups in the various mean
blood parameters, including anti-HCHO-HSA isotypes. The
titers for each isotype were converted to geometric means for
these analyses. Fischer exact tests, odds ratios, and 95%
confidence intervals (CI) werecalculatedtodeterminewhether
the Crown Point residents were at a higher risk for auto-
antibodies. Correlationanalysis wasperformedtodetermineif
age and gender affected lymphocyte subsets and anti-HCHO-
HSA isotypes. Analysis of variance was used to determine
whether smoking status and mobile home residency affected
HCHO-HSAisotypesandCD26cells. TheBonferroniinequal-
ity was employed.
Results
Formaldehyde Concentrations
HCHOlevelsinairsamples atvarious sitesrangedfrom0.007
to0.093 ppm, with an averageof0.023 ppm on March 5 and6.
Snowlevelconcentrationshada6-dayaverageof0.515ppmand
a 1-monthaverageof0.346ppminCrownPoint. HCHOconcen-
trationsintheventedgaseswere 17ppmand210,000ppmintank
liquids. Snow values immediately beneath the tank car ranged
from26.5to9900ppm. Backgroundsnowlevelsremotefromthe
spill were < 0.001 ppm.
EstimatesofHCHOconcentration intheplumeranged from
5 ppm(CrownPoint) to0.1 ppm (about3 miles southeast) dur-
ingthefirst48hr. TheexposuretoCrownPointresidentswasin
excess of2.0 ppm for this period oftime. TMA was noted as
detected (detection limit < 0.20 ppm).
SymptomsofCrownPointResidents
TheAlaskaDepartmentofHealthandSocialServicesreport-
edinitialmultiplesymptoms inCrownPointresidentsconsistent
with HCHO exposure. Examples were nasal congestion
(70.3%), sorethroat(65%), headache(62%), cough (54.9%),
conjunctivitis (51.5%), fatigue (51%), rash (47.5%), dizziness
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(40.4%), diarrhea (38.6%), shortness ofbreath (38%), nausea
(37%), and nose bleeds (25.7%). Fifty percent had recurrent,
unresolved health complaints approximately 60 days following
the spill. Identical symptoms for the Cooper Landing group
were 34, 25, 10.9, 14.1, 10.9, 20.0, 10.9, 15.6, 9.4, 6.3, and
5.0%, respectively.
Effects ofAge, Gender, Wood Stoves, Mobile
Homes, and Smoking
Correlation analysis for the effects of age and gender within
groups on observed mean values of immune parameters were
not significant. The absolute numbers and percent CD26 cells
and the geometric mean titers ofIgM and IgG isotypes were
consistently elevated in male and female Crown Point residents
versus their Cooper Landing counterparts.
The use of wood stoves and previous residency in mobile
homes did not correlate with antibodies to HCHO-HSA or
elevated CD26 cells. For example, of the seven subjects in
Crown Point who used wood stoves, three had isotypes to
HCHO-HSA and four did not. Only two subjects in Cooper
Landing had wood stoves, of which one had IgM (1:8) an-
tibodies to HCHO-HSA.
During the previous 10 years, 10 Cooper Landing residents
and 7 Crown Point residents had lived in mobile homes.
The duration of occupancy ranged from 2 months to 17
years in (Cooper Landing) and 6 weeks to 6 years (Crown
Point). Analysis of variance revealed no difference in mean
values ofCD26 cells or isotypes ofHCHO-HSA. No IgG anti-
HCHO-HSA isotypes were found in the Cooper Landing
group with respect to either mobile home residency or wood
stove usage.
The effect of smoking history on CD26 cells and IgG and
IgM isotypes to HCHO-HSA in CP is given in Table 1. F
values were not statistically significant.
HCHO-HSA Antibodies
The geometric mean titers ofIgE, IgM, and IgG isotypes to
HCHO-HSA for Crown Point and Cooper Landing subjects
are given in Table 2. IgE isotypes were not different in the two
groups. IgM and IgG titers were significantly higher in Crown
Point group versus Cooper Landing residents, p < 0.005 and
p < 0.0005, respectively.
WBC and Lymphocyte Subsets
The absolute counts for WBC, total lymphocytes, CD5,
CD4, and CD8 cells and the CD4/CD8 ratio did not differ in
the two groups (Table 3). However, the percentage ofCD5 and
CD4 cells in the peripheral blood was lower in the Crown
Point versus the Cooper Landing residents (p < 0.05).
CD19, CD25, and CD26 Cells
No difference between Crown Point and Cooper Landing
subjects was found in the absolute and percent CD19 and
CD25 cells (Table 4). The CD26 cells were significantly
elevated (p < 0.0001) in both absolute and percentages in the
Crown Point group versus the Cooper Landing residents.
Table 1. Comparison ofmean (±SD) valuesoffourbloodtestsforCrown
Pointcategorizedbyhistoryofcigarettesmoking.'
Test Smoker Ex-smoker Nonsmoker F p-value
CD26, 350.7 ± 425.3 293.2 ± 219.2 246.5 ± 253.7 0.45 NSb
number (13) (6) (22)
CD26, % 10.6 ± 9.5 12.0 ± 11.5 9.6 ± 10.4 0.14 NS
(13) (6) (22)
IgG 2.69 ± 0.86 3.33 ± 1.03 2.57 ± 0.951.63 NS
(13) (6) (23)
IgM 2.62 ± 1.04 3.17 ± 0.98 2.40 ± 0.721.92 NS
(13) (6) (23)
'Total numbers foreach category are in parentheses.
bNS, nonsignificant.
Table 2. Geometric mean (±SD) titers ofIgG, IgM, and IgE isotypes to
HCHO-HSA intheexposed and unexposed subjects.
Crown
Point
Isotypes (n = 42)
IgE 2.12 ± 0.45
IgM 2.57 ± 0.89
IgG 2.71 ± 0.95
aTwo patients did not have titersperformed.
bNS, nonsignificant.
Cooper
Landing
(n = 27)'
2.00 ± 0.00
2.11 ± 0.42
2.00 ± 0.00
p-value
NSb
< 0.005
< 0.0005
Nble3. Mean(±SD)absolutenumbersofWBCs,lymphoctes,andpercent
T-cellsalongwithCD4/CD8ratiofound inthe peripheral blood inthe ex-
posedandunexposedcommunities.'
Crown Cooper
Point Landing
(n = 41) (n = 29)
Absolute numbers, Absolute numbers,
Cell type cells/cm3 blood cells/cm3 blood p-value
WBC 6853.66 ± 1543.88 6886.21 ± 1525.84 NSb
Lymphocytes 2744.56 ± 892.05 2517.24 ± 550.37 NS
CD5(%) 1919.10 ± 681.14 1905.69 ± 461.19 NS
(70.02 ± 10.11) (75.55 ± 5.57) (<0.05)
CD4(%) 1322.90 ± 466.99 1336.48 ± 323.62 NS
(48.34 ± 8.58) (53.07 ± 4.74) (< 0.05)
CD8(%) 644.56 ± 251.26 596.55 ± 174.86 NS
(24.71 ± 7.26) (23.69 ± 4.53) NS
CD4/CD8 2.12 ± 0.68 2.24 ± 0.59 NS
aExpectedranges: WBC(4,500-10,300); lymphocytes (1,500-4,000); CD5
(8,00-2,530, 65-79%); CD4(480-1,185, 35-55%); CD8(220-865, 20-36%);
CD4/CD8 (1.65-2.30).
bNS, nonsignificant.
Autoantibodies
Thefrequencyofeachautoantibody wasconsistentlyhigher,
althoughnotstatisiticallysignficant, intheCrownPointversus
theCooperLandinggroups(Table5). However, whentheper-
centofautoantibodiespresentineachgroupwasexamined, the
CrownPointgrouphadasignificantly greaterodds ratio (95%
CI)ofhavingoneormoreautoantibodies versustheCooperLan-
ding residents (Fisher's exacttest,p < 0.004).
Discussion
TheresidentsofCrownPointexperiencedexposuretoHCHO
whichmostlikelyexceededtheOccupational SafetyandHealth
Administration 8-hrtime-weightedaverageof1.0ppm(16). For
example, HCHOconcentrations duringthefirst48hrafterthe
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Table4. Themean(±SD)absolutenumbers,percentages,andt-andp-values
obtained for CD19, CD25, and CD26 cells in the exposed and unexposed
subjects.'
Crown Point Cooper Landing
(n = 41) (n = 29)
Absolute numbers, Absolute numbers,
Cell type cell/cm3 blood cells/cm3 blood t-value p-value
CDl9(%) 232.02 ± 244.80 201.93 ± 64.63 0.75 NSb
(7.78 ± 6.73) (8.03 ± 2.01) 0.22 NS
CD25(%) 80.39 ± 90.10 61.38 ± 42.42 1.15 NS
(2.83 ± 3.19) (2.45 ± 1.66) 0.65 NS
CD26(%) 286.34 ± 310.29 52.10 ± 43.06 4.77 < 0.0001
(10.27 ± 10.06) (2.14 ± 1.83) 5.06 < 0.0001
aExpected ranges: CD19 (60-400, 4-15%); CD25 (0-320, 0-8%); CD26
(0-160,0-4%).
bNS, nonsignificant.
Table 5. Summaryofthe percentofeachautoantibody detectedinthesera
of residents at Crown Pbint versus those ofCooper Landing.
Crown Point Cooper Landing Odds
Autoantibodya (n = 42) (n = 27) ratios 95% CI
ASS 35.7 14.8 3.2 10.98,0.93
APA 16.7 3.7 5.2 44.97,0.60
ABB 14.3 3.7 4.6 39.60,0.50
AMA 2.4 0.0 - -
ANA 9.5 0.0 - -
Number ofautoantibodies
I or more 50.0 14.8 5.8 19.50, 1.0
2 or more 11.90 3.7 7.1 59.70,0.84
3 or more 7.1 3.7 2.0 20.20,0.19
'ASS, antismooth muscle; APA, antiparietal cells; ABB, antibrush border;
AMA, antimitochondrial; ANA, antinuclear.
spill were estimated to be between 2 to 5 ppm in Crown Point
(10). In addition, HCHO exposure continued for several more
days or evenweeks as a resultofsnow contamination and emis-
sions from other reactants (HMTA, TMA, and PF) (9). Thus,
it appears most likely that the Crown Point residents sustained
continuous, low-level exposureto HCHOand reactantsintheir
homes as well as from their immediate environment. Such ex-
posureconditions wouldbeconducivetocontinuinghealthpro-
blems such asthosedescribed in otherenvironmentswith low-
level HCHO(5,16). Moreover, theAlaskaDepartmentofHealth
and Social Services reportedrecurring symptomsapproximately
2 months following the accident (8).
Initially wewereconcernedaboutvariousuncontrolledpara-
meters that might affect the tests performed on the peripheral
bloodofbothCrownPointandCooperLandingresidents. These
includedage, gender, smoking, mobilehomeresidency, and use
ofwood stoves. Statistical analyses revealed noaffectby either
age or gender on absolute numbers and percentages ofF-cells
andtheirsubsets. Thisconfirmedourpreviousobservations(5).
Moreover, analysisofvariancerevealed noaffectofsmokingand
mobile home residency on isotypes to HCHO-HSA and CD26
cells. Theseobservations failed to reveal prior sensitization to
HCHO in either Crown Point or Cooper Landing residents.
Therefore, thedata weregrouped for furthercomparisons bet-
ween the two groups.
The significantly higher titers ofIgM and IgG antibodies to
HCHO-HSA intheCrownPointgroupcomparedtotheCooper
Landingresidents isindicativeofasystemic humoral response
toHCHO(Table 2). Similarresponseshavebeendemonstrated
in other environmental settings (1,2,5). In the Crown Pbint
subjects, we were able to show that the anti-HCHO-HSA an-
tibodies were independentofthe history ofsmoking (Table 1),
useofwoodstoves, andoccupancy inmobilehomes. Thelatter
was initially surprisingbecauseofpreviousdemonstrationofa
relationship between mobile homes and anti-HCHO-isotypes
(2,5). However, forthemostpart, subjectsinbothCrownPoint
andCooper Landinglived inmobilehomesforshortperiodsof
time(usuallyweeks)duringthepast 10years. Thus, itwouldap-
pear that their residencies were of insufficient duration to ap-
preciably affect the results obtained on HCHO-HSA isotypes,
CD26 cells, and autoantibodies.
Althoughthetotal whitecellcount, lymphocytesandT-cells,
andhelper/suppressorratiosintheCrownPointresidentsdidnot
differfromtheCooperLandinggroup,theCrownPNintsubjects
haveevidenceofanactivatedcellmediatedimmunity (Table4).
First, theCD26cellsaresignificantlyelevatedincomparisonto
the Cooper Landinggroup(p < 0.0001). CD26expressionoc-
curswithantigenicstimulation, and, therefore, isconsideredan-
tigenmemorycells(14,15,17). Moreover,circulatingCD26cells
and la-positive cells are elevated in various autoimmune
disorders (18-20). Recently, we demonstrated the elevation of
CD26 cells in individuals with chronic health complaints
associatedwith inhalationexposuretoHCHO, isocyanates, and
chlordane(5,21,22). SinceanincreaseincirculatingCD26cells
occurs in individuals undergoing chronic stimulation (i.e.,
chemicalsensitivity, autoimmunity), itappearsthatsomeofthe
CrownPointresidentsinthisstudyhaveachronicbutsubtleac-
tivation ofthe immune system. Recently, ithas beensuggested
thatindividualswithchronicfatiguesyndromehaveachronically
activatedimmunesystemevidencedbyavarietyofimmunologic
abnormalities, including autoantibodies (23).
Itisrecognizedthatenvironmentalchemicalsandtherapeutic
drugs are associated with autoantibodies, i.e., lupuslike syn-
drome (24,25). The observations made on the Crown Point
residents inthisstudyareconsistentwithchemicalexposureand
thepresenceofautoantibodies(Table5). Also, wehaveprevious-
lydemonstratedlowtiterautoantibodies inindividualsexposed
toHCHO(3)andchlordane(22). Moreover, theoddsratioand
the Fischer exact tests for the presence ot autoantibodies are
statisticallysignificantwhenCrownPointsubjectsarecompared
totheCooperLandinggroup. Althoughtheclinicalsignificance
of detectable autoantibodies and elevated CD26 is unknown,
these immuneparameters areassociated withthesymptoms of
the Crown Point residents.
Atthepresenttime,autoimmunedisordershavenotbeenclini-
callydiagnosedinthesepatients.However,individualssuchasthe
CrownPointresidentswithknownchemicalexposureandsubse-
quentmultipleorgansymptomsshouldbeexaminedforautoim-
munity. In addition, they shouldbe monitored forany signs of
autoimmuneproblems and subtle alterations in their immune
system, i.e., activation. Finally,although wewerenotpartofthe
originalexposureassessment, itissubmittedthatitisnecessary
toreportthesetypesofobservationstomakeothersawareofthe
necessity fordeveloping better assessmentprotocols.
Inconclusion, measurementsofchanges inWBC,T-cells, and
helper/suppressor ratios inindividualswithapparentchemical
sensitivities appeartobeinadequateimmuneparameters to ex-
amine. Ifoneassumesthattheseindividuals arerespondingim-
munologically to environmental chemicals, the investigations
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intoautoimmunity andimmuneactivation aswell aspertubations
in the interleukins, leukotreins, prostaglandins, and other im-
munologic mediators appear to be fruitful areas of further
research(5-7,23,25-29). Thus, itappearsthatsystemic sensitivi-
ty to HCHO and probably other toxicants are real phenomena
andrequirefurtherresearchintothebasiccomponentsoftheim-
mune system.
NW thankGilbertSalizarandthetechnical staffforthekindassistanceinthisstudy.
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